Tag:
Israel
Latest Headlines
Latest Headlines
SNBL mending lab issues, while entangled with animal welfare issues in Israel
Almost two years after receiving an FDA warning letter citing 9 violations at its Everett, WA, laboratory, SNBL USA announced that it remedied 7 of them.
Medtronic to move Ventor ops, lay off 55
Bad news for employees of Medtronic's Ventor Technologies. The device giant is shuttering the unit's doors in Netanya, Israel, and transferring its R&D activity to other sites. Fifty-five employees will lose their jobs as a result of the decision.
Canines ID Pfizer fakes, discern brands
Pfizer's ( $PFE ) Israeli unit is lending a paw--actually, 8 paws--to help Finland crack down on counterfeit Viagra. Canines Springer and Willem can sniff out the top-selling erectile-dysfunction
GE to open new Israeli R&D center
General Electric is opening a multidisciplinary R&D center in Israel, Globes is reporting today. In addition to conducting research on water and clean energy, the center will focus on
U.S. biotechs look to bullish Tel Aviv exchange for IPOs
Over the last few years the Tel Aviv Stock Exchange loosened up on its rules for tech companies looking to go public, and new life science companies from around the world are knocking on its doors as
Israel wants flu vax made at home
The Israeli health ministry isn't content with contracting to buy vaccines against H1N1 "swine" flu; instead, the government has started negotiating with domestic pharma companies to set up a plant
Teva, Optimata to 'rescue' failed cancer drugs
Israel's Optimata and Teva Pharmaceutical Industries have teamed up to develop cancer drugs. The two say they will "efficiently rescue" failed advanced stage clinical trials. Teva will purchase the
Sun extends tender for Taro, again
Sun Pharmaceuticals announced today that it has once again extended its tender offer for Taro Pharmaceuticals. Sun wants Taro to comply with an order by the Israeli Supreme Court that the offer
Sun extends Taro offer pending court ruling
Sun Pharmaceuticals's subsidiary, Alkaloida Chemical Company, has extended its tender offer for Taro Pharmaceuticals until November 7, 2008, according to a statement released today. The two companies
Pharmos to cut ops in Israel
After a rough year, Pharmos Corporation announced in October of 2007 that it would be laying off half
